偉思醫療(688580.SH):今年將推進電刺激產品技術全面升級
格隆匯7月25日丨偉思醫療(688580.SH)近日在接待機構投資者調研時表示,2024年,公司瞄準產業技術前沿,將不斷推動產品的技術和性能升級,拓寬應用領域和適應症範圍。其中①磁刺激領域,公司積極佈局精準靶點治療抑鬱症、焦慮等臨牀應用,其中自動導航的MagNeuro ONE系列產品,24年內已順利完成取證上市流程,在傳統經顱磁刺激儀的基礎上,引入了腦部磁共振相關醫學影像處理分析系統,可實現經顱磁刺激治療自動閾值檢測、靶點精準定位、智能實時隨動等特點,有效提升刺激靶點和刺激劑量的智能精準化水平,從而顯著提高臨牀治療效果;②電刺激領域:今年將推進電刺激產品技術全面升級,研發更符合臨牀應用的下一代電刺激產品;③電生理等領域:推進多款電生理核心產品兒童版本開發,擴充兒童康復產品矩陣;④激光射頻等其他能量源設備領域:聚焦康復市場主流需求,進一步擴充康復理療類設備產品矩陣,推進皮秒激光產品開發進展,爭取完成取證上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.